David Ramos, APRN

NPI: 1114227436
Total Payments
$10,454
2024 Payments
$3,217
Companies
41
Transactions
530
Medicare Patients
708
Medicare Billing
$64,785

Payment Breakdown by Category

Food & Beverage$10,454 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,454 530 100.0%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $1,604 83 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,045 44 $0 (2024)
Lilly USA, LLC $983.91 55 $0 (2024)
GlaxoSmithKline, LLC. $971.78 51 $0 (2024)
ABBVIE INC. $834.81 43 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $779.50 34 $0 (2024)
PFIZER INC. $594.66 39 $0 (2024)
Abbott Laboratories $517.79 29 $0 (2024)
Amgen Inc. $354.17 14 $0 (2024)
Rigel Pharmaceuticals, Inc. $309.38 13 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,217 163 AstraZeneca Pharmaceuticals LP ($513.63)
2023 $2,684 141 Novo Nordisk Inc ($497.53)
2022 $2,825 134 Novo Nordisk Inc ($430.82)
2021 $1,728 92 Boehringer Ingelheim Pharmaceuticals, Inc. ($258.97)

All Payment Transactions

530 individual payment records from CMS Open Payments — Page 1 of 22

Date Company Product Nature Form Amount Type
12/23/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $4.94 General
Category: Oncology
12/20/2024 SHIELD THERAPEUTICS INC ACCRUFER (Drug) Food and Beverage In-kind items and services $19.91 General
Category: Hematology
12/18/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $27.77 General
Category: Diabetes
12/18/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $8.80 General
Category: Diabetes
12/17/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $21.32 General
Category: Cardiovascular and Metabolism
12/12/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $19.00 General
Category: Cardiovascular
12/10/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $22.38 General
Category: Oncology
12/09/2024 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, ABRYSVO Food and Beverage In-kind items and services $21.12 General
Category: VACCINES
12/05/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $31.26 General
Category: Diabetes
12/02/2024 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Food and Beverage Cash or cash equivalent $25.22 General
Category: Acute Myeloid Leukemia
11/25/2024 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Food and Beverage Cash or cash equivalent $20.87 General
Category: Acute Myeloid Leukemia
11/23/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $24.31 General
Category: Cardiovascular and Metabolism
11/21/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.07 General
Category: NEUROSCIENCE
11/19/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $16.99 General
Category: Diabetes
11/14/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $20.21 General
Category: Diabetes
11/14/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $13.41 General
Category: Respiratory
11/13/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $13.26 General
Category: RESPIRATORY
11/12/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $3.48 General
Category: GASTROENTEROLOGY
11/08/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $24.07 General
Category: GASTROENTEROLOGY
11/06/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.63 General
Category: NEUROSCIENCE
10/30/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $23.84 General
Category: Anticholinergics, Inhaled
10/25/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $17.35 General
Category: RESPIRATORY
10/23/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.10 General
Category: NEUROSCIENCE
10/22/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $24.20 General
10/21/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $21.85 General
Category: CARDIOVASCULAR;METABOLIC DISEASE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 142 177 $39,363 $14,357
2022 3 155 223 $49,137 $17,611
2021 4 199 239 $50,533 $19,074
2020 4 212 241 $45,409 $13,742
Total Patients
708
Total Services
880
Medicare Billing
$64,785
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 67 100 $22,400 $7,095 31.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 58 58 $14,094 $6,472 45.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 17 19 $2,869 $789.97 27.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 79 140 $31,360 $9,603 30.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 57 57 $13,851 $6,430 46.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 19 26 $3,926 $1,578 40.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 69 69 $16,767 $7,973 47.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 71 102 $22,848 $6,996 30.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 33 42 $6,342 $2,243 35.4%
99497 Advance care planning by the physician or other qualified health care professional, first 30 minutes Office 2021 26 26 $4,576 $1,863 40.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 63 63 $15,309 $6,268 40.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 57 72 $16,128 $4,072 25.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 74 88 $13,288 $3,126 23.5%
G0444 Annual depression screening, 15 minutes Office 2020 18 18 $684.00 $275.92 40.3%

About David Ramos, APRN

David Ramos, APRN is a Family healthcare provider based in Riverside, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2010. The National Provider Identifier (NPI) number assigned to this provider is 1114227436.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Ramos, APRN has received a total of $10,454 in payments from pharmaceutical and medical device companies, with $3,217 received in 2024. These payments were reported across 530 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($10,454).

As a Medicare-enrolled provider, Ramos has provided services to 708 Medicare beneficiaries, totaling 880 services with total Medicare billing of $64,785. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Riverside, RI
  • Active Since 11/03/2010
  • Last Updated 09/25/2023
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1114227436

Products in Payments

  • TRELEGY ELLIPTA (Drug) $799.77
  • Ozempic (Drug) $709.20
  • JARDIANCE (Drug) $697.74
  • Rybelsus (Drug) $531.54
  • BREZTRI (Drug) $438.48
  • UBRELVY (Drug) $358.71
  • MOUNJARO (Drug) $342.35
  • Rezlidhia (Drug) $309.38
  • FREESTYLE LIBRE 3 (Device) $304.11
  • ELIQUIS (Drug) $274.96
  • AIRSUPRA (Drug) $272.98
  • FARXIGA (Drug) $267.05
  • Wegovy (Drug) $246.05
  • VRAYLAR (Drug) $238.39
  • STIOLTO RESPIMAT (Drug) $229.06
  • XPOVIO (Drug) $201.15
  • XARELTO (Drug) $197.05
  • Cologuard Collection Kit (Device) $183.47
  • Yupelri (Drug) $179.80
  • AREXVY (Drug) $172.01

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Riverside